Literature DB >> 7506464

E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma.

T Otto1, K Rembrink, M Goepel, M Meyer-Schwickerath, H Rübben.   

Abstract

Considerable controversy exists concerning the value of histomorphological data in the assessment of the malignant potential of prostatic carcinomas. We investigated the expression pattern of E-cadherin in human prostate at the translational level. E-cadherin is a specific epithelial cell-cell adhesion molecule which has previously been found to be expressed in well-differentiated non-invasive carcinoma cell lines but is lost in many poorly differentiated invasive cell lines. The E-cadherin expression pattern in the prostate samples was correlated with histopathological findings in the same specimens. We found strong E-cadherin expression in normal prostate and benign prostatic hyperplasia. A decrease in or loss of E-cadherin was seen in 13 of 14 locally advanced and in 8 of 9 poorly differentiated prostatic carcinomas. We conclude that downregulation of E-cadherin expression plays a role in prostate carcinogenesis and invasiveness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506464     DOI: 10.1007/bf00296837

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  29 in total

1.  Occult carcinoma of the prostate; clinical and therapeutic study of eighty-three cases.

Authors:  L F GREENE; H B SIMON
Journal:  J Am Med Assoc       Date:  1955-08-27

2.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

3.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.

Authors:  T A Stamey; J N Kabalin
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

4.  Tumor cell autocrine motility factor.

Authors:  L A Liotta; R Mandler; G Murano; D A Katz; R K Gordon; P K Chiang; E Schiffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial.

Authors:  H B Muss; V Howard; F Richards; D R White; D V Jackson; M R Cooper; J J Stuart; M I Resnick; R Brodkin; C L Spurr
Journal:  Cancer       Date:  1981-04-15       Impact factor: 6.860

6.  Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA.

Authors:  A Nagafuchi; Y Shirayoshi; K Okazaki; K Yasuda; M Takeichi
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

7.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

8.  Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate.

Authors:  M S Soloway; J B deKernion; R P Gibbons; D E Johnson; S A Loening; J E Pontes; G R Prout; J D Schmidt; W W Scott; T M Chu; J F Gaeta; N H Slack; G P Murphy
Journal:  J Urol       Date:  1981-05       Impact factor: 7.450

9.  Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin.

Authors:  J Behrens; W Birchmeier; S L Goodman; B A Imhof
Journal:  J Cell Biol       Date:  1985-10       Impact factor: 10.539

10.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells.

Authors:  K M Weidner; J Behrens; J Vandekerckhove; W Birchmeier
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

View more
  18 in total

1.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

Authors:  M Y Hsu; F E Meier; M Nesbit; J Y Hsu; P Van Belle; D E Elder; M Herlyn
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.

Authors:  W G Jian; S J Darnton; K Jenner; L J Billingham; H R Matthews
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

3.  Expression of E-cadherin in primary and metastatic prostate cancer.

Authors:  L Cheng; M Nagabhushan; T P Pretlow; S B Amini; T G Pretlow
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells.

Authors:  N L Tran; R B Nagle; A E Cress; R L Heimark
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 5.  Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?

Authors:  I R Beavon
Journal:  Mol Pathol       Date:  1999-08

Review 6.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

7.  Defining aggressive prostate cancer using a 12-gene model.

Authors:  Tarek A Bismar; Francesca Demichelis; Alberto Riva; Robert Kim; Sooryanarayana Varambally; Le He; Jeff Kutok; Jonathan C Aster; Jeffery Tang; Rainer Kuefer; Matthias D Hofer; Phillip G Febbo; Arul M Chinnaiyan; Mark A Rubin
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

8.  Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.

Authors:  Donghong He; Yanlin Su; Peter V Usatyuk; Ernst Wm Spannhake; Paul Kogut; Julian Solway; Viswanathan Natarajan; Yutong Zhao
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

9.  Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.

Authors:  Hui He; Xiaojian Yang; Alec J Davidson; Daqing Wu; Fray F Marshall; Leland W K Chung; Haiyen E Zhau; Ruoxiang Wang
Journal:  Prostate       Date:  2010-04-01       Impact factor: 4.104

Review 10.  Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors.

Authors:  Rodolfo Montironi; Marina Scarpelli; Antonio López Beltran
Journal:  Virchows Arch       Date:  2004-03-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.